Clinical studies recruiting near Murrieta

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Phase 1/Phase 2 · Urology Center of Southern California · SURGE Therapeutics · NCT05710848 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · Research Site 152 · Locus Biosciences · NCT05488340 Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants
NA · Rancho Springs Medical Center Rady NICU · University of California, San Diego · NCT06123143 Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Phase 2 · Urology Center of Southern California · CG Oncology, Inc. · NCT06567743 Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · Esperanza Clinical · Exciva GmbH · NCT07284472 Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
NA · Loma Linda University Professional Building - Murrieta · Loma Linda University · NCT05575401 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · United Medical Doctors CA-Site Number: 8400044 · Sanofi · NCT07184931 Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NA · Tri Valley Urology · Axonics, Inc. · NCT06511141 A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurre
Phase 3 · Valkyrie Clinical Trials Murrieta · Janssen Research & Development, LLC · NCT07276399 Supraglottic Airway for Resuscitation Trial
NA · Rady Children's NICU at Rancho Springs Medical Center · Children's Hospital of Philadelphia · NCT07150923 Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria
Phase N/A · Tri Valley Urology Medical Group · Pacific Edge Limited · NCT05889195 An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants W
Phase 2 · LoBue Laser and Eye Medical Center · Dompé Farmaceutici S.p.A · NCT07503886 Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Phase 2 · United Medical Doctors · Abivax S.A. · NCT06456593 A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Acti
Phase 3 · United Medical Doctors CA - Site Number: 8400044 · Sanofi · NCT07185009 Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 2 · United Medical Doctors · Gilead Sciences · NCT06029972 A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
Phase 2/Phase 3 · LoBue Laser and Eye Medical Center · Oculis · NCT07548632 Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Meta
Phase 1/Phase 2 · Valkyrie Clinical Trials · Inhibrx Biosciences, Inc · NCT04198766 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · University Surgery Center · Stryker Instruments · NCT03072927 A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to
Phase 2 · United Medical Doctors · Takeda · NCT06233461 A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's
Phase 2 · Esperanza Clinical · Neuron23 Inc. · NCT06680830 Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Blad
Phase 2 · Tri Valley Urology - Murrieta · Tyra Biosciences, Inc · NCT06995677 A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Phase 2 · Clinical Site · MapLight Therapeutics · NCT06887192 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · United Medical Doctors CA - Site Number: 8400044 · Sanofi · NCT07184996 A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, f
Phase 2 · Valkyrie Clinical Trials Murrieta · Janssen Research & Development, LLC · NCT06667076 Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Can
Phase 3 · Urology Center of Southern California · Ferring Pharmaceuticals · NCT06510374 [18F]PI-2620 Phase 3 Histopathological Study
Phase 3 · Esperanza Clinical · Lantheus Biosciences Ltd. · NCT05641688 A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome
Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT07519395 A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Phase 4 · Inland Empire Gastroenterology · Takeda · NCT06581328 A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · United Medical Doctors - Murrieta · Eli Lilly and Company · NCT07165028

Look up another city

Look up another condition